1. Comparison of long‐term outcome of patients with ST‐segment elevation myocardial infarction between pre‐COVID‐19 and COVID‐19 era.
- Author
-
Kiris, Tuncay, Avci, Eyüp, Ekin, Tuba, Akgün, Didar Elif, Tiryaki, Mücahit, Yidirim, Arafat, Hazir, Kutluhan, Murat, Bektaş, Yeni, Mehtap, Altindag, Rojhad, Gül, Sefa, Arik, Baran, Güzel, Tuncay, Murat, Selda, Oz, Ahmet, Karabacak, Mustafa, Aktas, Zihni, Yildirim, Tarik, Kilicaslan, Baris, and Ergene, Asim Oktay
- Subjects
- *
ST elevation myocardial infarction , *COVID-19 - Abstract
Aims: To compare major cardiovascular and cerebrovascular events (MACCE) rates between patients in the pre‐COVID‐19 era and COVID‐19 era, and to assess the impact of the presence of COVID‐19 (+) on long‐term MACCE in ST‐segment elevation myocardial infarction (STEMI) in Turkey. Methods: Using the TURSER study (TURKISH ST‐segment elevation myocardial infarction registry) data, the current study included 1748 STEMI patients from 15 centres in Turkey. Patients were stratified into COVID‐19 era (March 11st–May 15st, 2020; n = 723) or pre‐COVID‐19 era (March 11st–May 15st, 2019; n = 1025) cohorts. Long‐term MACCE rates were compared between groups. In addition, the effect of COVID‐19 positivity on long‐term outcomes was evaluated. The primary outcome was the occurrence of MACCE at long‐term follow‐up, and the secondary outcome was hospitalization with heart failure. Results: The MACCE and hospitalization with heart failure rates between pre‐COVID‐19 era and COVID‐19 era were 23% versus 22% (p =.841), and 12% versus 8% (p =.002), respectively. In the COVID‐19 era, the rates of MACCE and hospitalization with heart failure COVID‐19‐positive versus COVID‐19‐negative patients were 40% versus 20%, (p <.001), and 43% versus 11% (p <.001), respectively. Conclusion: There was no difference between the pre‐COVID‐19 era and the COVID‐19 era in terms of MACCE in STEMI patients in Turkey. In the COVID‐19 era, STEMI patients positive for COVID‐19 had a higher rate of MACCE and heart failure hospitalization at the long‐term follow‐up. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF